Prevalence of Adult Asthma Has Increased in the United States
The prevalence of adult asthma in the United States increased between 2009 and 2014 before levelling out between 2015 and 2018.
Asthma
Asthma, COPD Inhaler Medication Adherence Trends During COVID-19
Patients with asthma and COPD appear to have increased their adherence to inhaler medications in the wake of the COVID-19 pandemic.
COVID-19-Related Genes Have Higher Expression in Certain Patients With Asthma
In patients with COVID-19, higher sputum cell expression of ACE2 and TMPRSS2 was observed in certain patients while lower expression was found in patients who used inhaled corticosteroids.
Single-Inhaler Therapy vs Multiple-Inhaler Triple Therapy Outcomes in COPD
In patients with COPD, treatment with single-inhaler fluticasone furoate/umeclidinium/vilanterol resulted in more health status improvements and greater lung function benefit compared with multiple-inhaler triple therapy.
Age Does Not Influence Efficacy of Tiotropium Bromide in Adults With Asthma
In patients with asthma, age does not appear to influence the efficacy of once-daily tiotropium bromide when used as an add-on to ICS and ICS/ LABA therapy.
Masitinib Significantly Reduced Exacerbations in Uncontrolled Severe Asthma
The first-in-class tyrosine kinase inhibitor masitinib decreased asthma exacerbations greater than placebo in patients with severe asthma uncontrolled by oral corticosteroids.
Discontinuing Mepolizumab Decreases Asthma Control, Increases Eosinophil Counts
Patients with severe eosinophilic asthma who are treated with mepolizumab and subsequently stop treatment have increased blood eosinophil counts and increased exacerbations, among other negative clinical outcomes.
Asthma-COPD Overlap May Be Independent Risk Factor for Lung Cancer
Patients with asthma-chronic obstructive pulmonary disease overlap may have an increased independent risk for lung cancer that is similar to those with COPD, but higher than smokers with asthma and normal spirometry values.
Inhaled Anti-TSLP May Be Promising New Treatment for Adults With Mild Asthma
CSJ117, formulated as an engineered powder in hard capsules for delivery to the lungs via dry powder inhaler, may be the first inhaled anti-thymic stromal lymphopoietin treatment for adults with mild asthma.
Asthma-Specific Questionnaires May Identify Psychological Comorbidities in Chronic Disease
Asthma-specific questionnaires may reveal a more targeted method for identifying psychological comorbidities in patients with chronic asthma.
Next post in Asthma
